(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
Psychosis
A research study of an investigational medication for patients with Parkinson's disease and psychosis. Volunteers with a clinical diagnosis of idiopathic Parkinson's disease who also exhibit symptoms of psychosis, defined by the presence of visual and/or auditory hallucinations, with or without delusions of at least four weeks duration, may be able to participate. Research site located in Schenctady, NY.
More Information
Please see http://www.centerwatch.com/patient/studies/cat448.jspl.
-----
Prostate Cancer
A research study of a combination of medications in the treatment of patients with androgen-independent prostate cancer that has metastasized to bone. Men at least 18 years of age who have metastatic, histologically or cytologically confirmed adenocarcinoma of the prostate that has progressed after the start of androgen deprivation therapy may be eligible. Research sites located throughout the United States.
More Information
Please see http://www.centerwatch.com/patient/studies/cat36.jspl.
-----
Generalized Anxiety Disorder (GAD)
A research study of an investigational medication for the treatment of generalized anxiety disorder (GAD). Volunteers who have symptoms of GAD such as feeling tense, irritable, having trouble concentrating, worrying a lot even over small matters, have difficulty sleeping, upset stomach, and rapid heartbeat may be eligible. Research site located in New York, NY.
More Information
Please see http://www.centerwatch.com/patient/studies/cat414.jspl.
----- |
